2011
DOI: 10.1002/ijc.26463
|View full text |Cite
|
Sign up to set email alerts
|

Expression of ER stress and autophagy‐related molecules in human non‐small cell lung cancer and premalignant lesions

Abstract: Stress that impairs endoplasmic reticulum (ER) function leads to an accumulation of unfolded or misfolded proteins in the ER (ER stress). Autophagy is a lysosomal pathway involved in the turnover of cellular macromolecules and organelles, which emerging data indicate that ER stress is also a potent inducer of autophagy. ER stress and autophagy are involved in human cancer. We examined the expression of ER stress-related proteins [GRP78 and C/EBP homologous protein (CHOP)] and autophagic proteins (Beclin-1 and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
40
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(45 citation statements)
references
References 35 publications
4
40
0
Order By: Relevance
“…Beclin1 and LC3 expressions were scored by the summation of the proportion of immunoreactive cells (0: 0%-9%, 1: 10%-49%, or 2: 50%-100%) and the staining intensity (0: no staining, 1: weak, 2: medium, or 3: strong), and a score of 4 or 5 was considered to represent strong expression, as previously described. 10 As previously described, 22 tumors with <10% cells with weak staining of mTOR were scored as 0, those with >10% cells with weak staining or <20% cells with intermediate-tostrong staining of mTOR were scored as 1, and those with >20% cells with intermediate-to-strong staining of mTOR were scored as 2, and a staining score of either 1 or 2 was considered to represent strong mTOR expression.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Beclin1 and LC3 expressions were scored by the summation of the proportion of immunoreactive cells (0: 0%-9%, 1: 10%-49%, or 2: 50%-100%) and the staining intensity (0: no staining, 1: weak, 2: medium, or 3: strong), and a score of 4 or 5 was considered to represent strong expression, as previously described. 10 As previously described, 22 tumors with <10% cells with weak staining of mTOR were scored as 0, those with >10% cells with weak staining or <20% cells with intermediate-tostrong staining of mTOR were scored as 1, and those with >20% cells with intermediate-to-strong staining of mTOR were scored as 2, and a staining score of either 1 or 2 was considered to represent strong mTOR expression.…”
Section: Methodsmentioning
confidence: 99%
“…8,9 Furthermore, inconsistent findings have been reported with respect to whether the expression profile of autophagyrelated markers is associated with the prognosis of patients with malignant tumors. [10][11][12][13][14] In the field of PC research as well, a few studies assessed the significance of molecular markers involved in autophagy. [15][16][17] For example, Giatromanolaki et al 17 reported that the strong and extensive expression of LC3 in PC specimens was closely associated with the Gleason score, whereas Jiang et al 16 showed the significant impact of the elevated expression of a mitochondrion-associated autophagy inhibitor, leucine-rich pentatricopeptide repeat motifecontaining protein, on the prognosis of PC patients at a late stage with a poor prognosis.…”
Section: Commentmentioning
confidence: 99%
See 1 more Smart Citation
“…Cancer CHOP expression in tumors correlates with stage, malignancy, and low survival in patients (Kim et al 2012;Dalton et al 2013). The incidence of K-ras (G12V)-induced lung cancer is markedly enhanced in the absence of CHOP (Huber et al 2013), suggesting an anticancer activity of CHOP.…”
Section: Chop/ddit3/gadd153mentioning
confidence: 99%
“…In previous studies, increased expression of GADD153 correlated with a lower tumor stage in colon cancer and with a higher survival rate in melanoma (33,34). A further study on lung cancer demonstrated that GADD153 expression correlated with a larger tumor size, higher pathological T stage, higher TNM stage and shorter overall survival rate (35). Therefore, we focused on the expression of GADD153 in patients with stage I (3) primary NSCLC and its association with clinical outcome.…”
Section: Discussionmentioning
confidence: 93%